GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31

GeoVax Labs, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 27, 2026

$0.23−0.01 (-4.53%)

Close on Oct 19, 2026

Market cap: $1.04M
P/E (TTM): –
Dividend yield: –

Dividends

GeoVax Labs has not reported a dividend

No dividend per share appears in GeoVax Labs's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in GeoVax Labs's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-25 reverse split on Jan 12, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GOVX.

Revenue growth-100.0% · median 52.0%

Company	Revenue	Growth
NWBO	$2.17M	+98.6%
VCNX	$601.00K	+5.4%
GOVX	$0	-100.0%
PVCT	–	–
ANIX	–	–
TRAW	–	–

Company

Next earnings (est.): Nov 12, 2026, during market hours
Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 19
Held by institutions: 6.7%
Auditor: WIPFLI LLP
SEC CIK: 832489

Advertisement
300 × 250